Ciladopa
Chemical compound
From Wikipedia, the free encyclopedia
Ciladopa (developmental code name AY-27,110) is a dopamine agonist with a similar chemical structure to dopamine.[1] It was under investigation as an antiparkinsonian agent but was discontinued due to concerns of tumorogenesis in rodents.[2][3][4][5]
| Clinical data | |
|---|---|
| Other names | AY-27,110 |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H26N2O4 |
| Molar mass | 370.449 g·mol−1 |
| 3D model (JSmol) | |
| |